WO2015118978A1 - Polyvinyl alcohol film - Google Patents
Polyvinyl alcohol film Download PDFInfo
- Publication number
- WO2015118978A1 WO2015118978A1 PCT/JP2015/052003 JP2015052003W WO2015118978A1 WO 2015118978 A1 WO2015118978 A1 WO 2015118978A1 JP 2015052003 W JP2015052003 W JP 2015052003W WO 2015118978 A1 WO2015118978 A1 WO 2015118978A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- film
- mass
- pva
- parts
- polyvinyl alcohol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/34—Shaped forms, e.g. sheets, not provided for in any other sub-group of this main group
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L29/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical; Compositions of hydrolysed polymers of esters of unsaturated alcohols with saturated carboxylic acids; Compositions of derivatives of such polymers
- C08L29/02—Homopolymers or copolymers of unsaturated alcohols
- C08L29/04—Polyvinyl alcohol; Partially hydrolysed homopolymers or copolymers of esters of unsaturated alcohols with saturated carboxylic acids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D65/00—Wrappers or flexible covers; Packaging materials of special type or form
- B65D65/02—Wrappers or flexible covers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D65/00—Wrappers or flexible covers; Packaging materials of special type or form
- B65D65/38—Packaging materials of special type or form
- B65D65/46—Applications of disintegrable, dissolvable or edible materials
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J5/00—Manufacture of articles or shaped materials containing macromolecular substances
- C08J5/18—Manufacture of films or sheets
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/0008—Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
- C08K5/0016—Plasticisers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/36—Sulfur-, selenium-, or tellurium-containing compounds
- C08K5/41—Compounds containing sulfur bound to oxygen
- C08K5/42—Sulfonic acids; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2329/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal, or ketal radical; Hydrolysed polymers of esters of unsaturated alcohols with saturated carboxylic acids; Derivatives of such polymer
- C08J2329/02—Homopolymers or copolymers of unsaturated alcohols
- C08J2329/04—Polyvinyl alcohol; Partially hydrolysed homopolymers or copolymers of esters of unsaturated alcohols with saturated carboxylic acids
Definitions
- the present invention relates to a polyvinyl alcohol film useful for unit packaging of chemicals such as agricultural chemicals and detergents, and a package using the same.
- a jumbo agent for paddy fields is an agrochemical active ingredient by dissolving the water-soluble film that wraps it in the paddy field and diffusing it throughout the paddy field by floating the jumbo agent contained in the package. Will spread. At this time, if the water-soluble film does not dissolve quickly or the diffusibility of the pesticidal active ingredient is insufficient, the pesticidal active ingredient cannot be distributed throughout the paddy field.
- a polyvinyl alcohol film As a water-soluble film used for unit packaging, a polyvinyl alcohol film (hereinafter, “polyvinyl alcohol” may be abbreviated as “PVA”) is known. Specifically, for example, a specific sulfonic acid group-containing film is used. A film using modified PVA having a unit (see Patent Document 1), a film containing PVA and a water-soluble sulfonate-containing compound (see Patent Document 2), and the like are known.
- an object of the present invention is to provide a PVA film that dissolves quickly after being poured into water and has excellent diffusibility of the packaged drug, and a package using the PVA film.
- the present invention [1] A PVA film containing PVA, a water surface spreading agent and a plasticizer, wherein the plasticizer content is 10 to 40 parts by mass with respect to 100 parts by mass of PVA; [2] The PVA film according to [1], wherein the content of the water surface spreading agent is 0.1 to 15 parts by mass with respect to 100 parts by mass of PVA; [3] The PVA film according to [1] or [2], wherein the water surface spreading agent is a dialkyl sulfosuccinate.
- a PVA film that dissolves rapidly after being poured into water and is excellent in diffusibility of the packaged medicine, and a package using the PVA film.
- the PVA film of the present invention contains PVA, a water surface spreading agent and a plasticizer.
- the plasticizer content is 10 to 40 parts by mass with respect to 100 parts by mass of PVA.
- the plasticizer is contained in the above-described content, it further becomes a PVA film that dissolves rapidly after being put into water and is excellent in diffusibility of the packaged medicine by containing the plasticizer.
- the PVA is one of vinyl esters such as vinyl acetate, vinyl formate, vinyl propionate, vinyl butyrate, vinyl pivalate, vinyl versatate, vinyl laurate, vinyl stearate, vinyl benzoate, and isopropenyl acetate. Or what is obtained by saponifying the polyvinyl ester obtained by superposing
- the above-mentioned polyvinyl ester may be obtained using only one or two or more kinds of vinyl esters as a monomer. It may be a copolymer of two or more kinds of vinyl esters and other monomers copolymerizable therewith.
- Examples of the other monomer copolymerizable with the vinyl ester include ⁇ -olefins having 2 to 30 carbon atoms such as ethylene, propylene, 1-butene, and isobutene; (meth) acrylic acid or a salt thereof; (Meth) methyl acrylate, (meth) ethyl acrylate, (meth) acrylate n-propyl, (meth) acrylate i-propyl, (meth) acrylate n-butyl, (meth) acrylate i-butyl, ( (Meth) acrylic acid esters such as t-butyl (meth) acrylate, 2-ethylhexyl (meth) acrylate, dodecyl (meth) acrylate, octadecyl (meth) acrylate; (meth) acrylamide, N-methyl ( (Meth) acrylamide, N-ethyl (meth) acrylamide, N,
- Vinyl ether vinyl cyanide such as (meth) acrylonitrile
- vinyl halide such as vinyl chloride, vinylidene chloride, vinyl fluoride, vinylidene fluoride
- Allyl compounds such as allyl acetate and allyl chloride; maleic acid or its salts, esters or acid anhydrides; itaconic acid or its salts, esters or acid anhydrides
- vinylsilyl compounds such as vinyltrimethoxysilane; unsaturated sulfonic acids be able to.
- Said polyvinyl ester can have a structural unit derived from 1 type, or 2 or more types of an above described other monomer.
- the proportion of structural units derived from the other monomers described above in the polyvinyl ester is preferably 25 mol% or less based on the number of moles of all structural units constituting the polyvinyl ester, and is 15 mol%. More preferably, it is more preferably 5 mol% or less.
- the above PVA may be modified with one or two or more types of graft copolymerizable monomers as long as the effects of the present invention are not impaired.
- the graft copolymerizable monomer include unsaturated carboxylic acids or derivatives thereof; unsaturated sulfonic acids or derivatives thereof; ⁇ -olefins having 2 to 30 carbon atoms, and the like.
- the proportion of structural units derived from the graft copolymerizable monomer in PVA (structural units in the graft modified portion) is preferably 5 mol% or less based on the number of moles of all structural units constituting PVA. .
- the PVA described above may be partially or not crosslinked in the hydroxyl group. Moreover, said PVA may react with aldehyde compounds, such as acetaldehyde and a butyraldehyde, etc. to form an acetal structure, and the said PVA does not react with these compounds and does not form an acetal structure. May be.
- aldehyde compounds such as acetaldehyde and a butyraldehyde, etc.
- the degree of polymerization of the PVA is not particularly limited, but is preferably 300 or more, more preferably 500 or more, further preferably 800 or more, particularly preferably 1,000 or more, It is preferably 10,000 or less, more preferably 8,000 or less, further preferably 5,000 or less, and particularly preferably 2,000 or less.
- the degree of polymerization degree being 300 or more, the intensity
- the degree of polymerization is 10,000 or less, industrial production of the PVA becomes easy.
- the degree of polymerization of PVA means the average degree of polymerization measured according to the description of JIS K6726-1994.
- the degree of saponification of the above PVA is not particularly limited, but is preferably 80 mol% or more, more preferably 82 mol% or more, and 84 mol% from the viewpoint of strength, waist and bag-making property of the obtained PVA film. % Or more, more preferably 99.9 mol% or less, more preferably 99 mol% or less, and even more preferably 98 mol% or less.
- degree of saponification of PVA is 80 mol% or more, sufficient elasticity can be imparted to the film, and the form stability is improved.
- an alkaline substance or acidic substance is packaged and stored in the film Moreover, the water-soluble fall of a film can be prevented more effectively.
- the degree of saponification of PVA refers to the total number of moles of structural units (typically vinyl ester units) that can be converted into vinyl alcohol units by saponification and the vinyl alcohol units of PVA.
- the degree of saponification can be measured according to the description of JIS-K6726-1994.
- the type of the water surface spreading agent is not particularly limited, but dialkylsulfosuccinate is preferable because the effects of the present invention are more remarkably exhibited.
- the dialkylsulfosuccinate is a compound having a structure corresponding to a structure in which two carboxyl groups in the sulfosuccinate are each converted to an alkyl ester, and is obtained by any production method as long as it has the structure. There may be.
- the alkyl groups in the two alkyl ester moieties of the dialkyl sulfosuccinate may be the same or different from each other, but are preferably the same from the viewpoint of ease of production. .
- either one or both of the alkyl groups in the dialkyl sulfosuccinate may be a linear alkyl group, or one or both may be a branched alkyl group.
- the alkyl group include methyl group, ethyl group, propyl group, isopropyl group, pentyl group, hexyl group, heptyl group, octyl group, 2-ethylhexyl group, nonyl group, decanyl group, undecanyl group, and dodecanyl group. Can be mentioned.
- At least one (preferably both) of the alkyl groups in the dialkylsulfosuccinate is preferably an alkyl group having 6 to 12 carbon atoms.
- An alkyl group of 7 to 10 is more preferable.
- at least one (preferably both) of the alkyl groups in the dialkylsulfosuccinate is preferably a linear alkyl group.
- Examples of the salt in the dialkylsulfosuccinate include inorganic salts, preferably sodium salt, potassium salt, and ammonium salt, and more preferably sodium salt.
- the content of the water surface broadening agent in the PVA film is such that the effects of the present invention are more remarkably achieved, and the high mechanical properties can be maintained and the handleability is improved. It is preferably 1 part by mass or more, more preferably 1 part by mass or more, further preferably 3 parts by mass or more, and preferably 15 parts by mass or less, and 14 parts by mass or less. More preferably, the amount is 12 parts by mass or less.
- plasticizer examples include polyhydric alcohols, and specific examples thereof include ethylene glycol, glycerin, propylene glycol, diethylene glycol, diglycerin, triethylene glycol, tetraethylene glycol, trimethylolpropane, and polyethylene glycol. Can be mentioned.
- the PVA film can contain one or more of these plasticizers. Among these, at least one selected from the group consisting of glycerin, diglycerin and polyethylene glycol is preferable.
- the number average molecular weight of polyethylene glycol is not particularly limited, but may be in the range of 100 to 1,000 from the viewpoint of compatibility with PVA and prevention of reduction in water solubility of the film due to bleeding out. preferable.
- the content of the plasticizer in the PVA film dissolves quickly after being poured into water, and becomes a PVA film excellent in the diffusibility of the packaged medicine. Therefore, the content of the plasticizer is within the range of 10 to 40% by mass with respect to 100 parts by mass of PVA.
- the content is preferably 12 parts by mass or more, more preferably 14 parts by mass or more, and preferably 38 parts by mass or less, and 36 parts by mass or less. More preferably.
- PVA films include starch and / or other than PVA. Another water-soluble polymer may be further contained.
- starch examples include natural starches such as corn starch, potato starch, sweet potato starch, wheat starch, rice starch, tapioca starch, and sago starch; processed starches subjected to etherification, esterification, oxidation, etc. In particular, modified starches are preferred.
- the starch content in the PVA film is preferably 15 parts by mass or less and more preferably 10 parts by mass or less with respect to 100 parts by mass of PVA.
- the content is 15 parts by mass or less, the impact resistance of the PVA film is improved and the process passability is improved.
- water-soluble polymers other than PVA include, for example, dextrin, gelatin, glue, casein, shellac, gum arabic, polyacrylic acid amide, sodium polyacrylate, polyvinyl methyl ether, methyl vinyl ether and maleic anhydride.
- examples thereof include a polymer, a copolymer of vinyl acetate and itaconic acid, polyvinyl pyrrolidone, cellulose, acetyl cellulose, acetyl butyl cellulose, carboxymethyl cellulose, methyl cellulose, ethyl cellulose, hydroxyethyl cellulose, and sodium alginate.
- the content of the water-soluble polymer other than PVA in the PVA film is preferably 15 parts by mass or less and more preferably 10 parts by mass or less with respect to 100 parts by mass of PVA. When the content is 15 parts by mass or less, the water solubility and dispersibility of the PVA film are improved.
- the PVA film further includes a filler, a processing stabilizer such as a copper compound, a weather resistance stabilizer, a colorant, an ultraviolet absorber, a light stabilizer, an antioxidant, an antistatic agent, a flame retardant, and other thermoplastic resins. , Lubricants, fragrances, antifoaming agents, deodorants, extenders, release agents, mold release agents, reinforcing agents, crosslinking agents, fungicides, preservatives, crystallization rate retarders, surfactants described later, etc. Additives can be appropriately contained as necessary.
- a processing stabilizer such as a copper compound, a weather resistance stabilizer, a colorant, an ultraviolet absorber, a light stabilizer, an antioxidant, an antistatic agent, a flame retardant, and other thermoplastic resins.
- Lubricants Lubricants, fragrances, antifoaming agents, deodorants, extenders, release agents, mold release agents, reinforcing agents, crosslinking agents, fungicides, preservatives
- the proportion of the total of the PVA, the water surface spreading agent and the plasticizer is preferably 80% by mass or more, more preferably 90% by mass or more based on the mass of the PVA film. And more preferably 95% by mass or more.
- the thickness of the PVA film is not particularly limited, but it is preferably 1 ⁇ m or more, more preferably 5 ⁇ m or more, further preferably 10 ⁇ m or more, and 100 ⁇ m or less from the viewpoint of both strength and water solubility. Preferably, it is 75 ⁇ m or less, and more preferably 60 ⁇ m or less.
- the shape of the PVA film is not particularly limited, and examples thereof include a quadrangle (for example, a rectangle, a square, etc.), a circle, a triangle, and the like, and can be appropriately set according to the usage form of the PVA film of the present invention.
- a long film is preferable because it can be continuously produced and can be easily stored and transported in a rolled state.
- the length of the long PVA film is not particularly limited, but is preferably 1 m or more, more preferably 100 m or more, and more preferably 1,000 m or more from the viewpoint of productivity during processing. preferable.
- the upper limit of the length is, for example, 10,000 m.
- the width of the long PVA film is not particularly limited, but is preferably 50 cm or more, more preferably 80 cm or more, and further preferably 100 cm or more from the viewpoint of productivity during processing. .
- An example of the upper limit of the width is 5 m.
- the PVA film can be used by cutting into a desired size when used.
- the production method of the PVA film of the present invention is not particularly limited, and a production method in which the thickness and width of the PVA film after film formation are more uniform can be preferably adopted.
- the film-forming stock solution contains at least one of starch, other water-soluble polymers and additives, it is preferable that these components are uniformly mixed.
- liquid medium used for the preparation of the membrane forming stock solution examples include water, dimethyl sulfoxide, dimethylformamide, dimethylacetamide, N-methylpyrrolidone, ethylene glycol, glycerin, propylene glycol, diethylene glycol, triethylene glycol, and tetraethylene glycol. , Trimethylolpropane, ethylenediamine, diethylenetriamine and the like, and one or more of them can be used. Among these, water is preferable from the viewpoint of environmental load and recoverability.
- the volatile fraction of the film-forming stock solution (content ratio in the film-forming stock solution of volatile components such as liquid media removed by volatilization or evaporation during film formation) varies depending on the film-forming method, film-forming conditions, etc. Specifically, it is preferably in the range of 50 to 95% by mass, more preferably in the range of 55 to 90% by mass, and still more preferably in the range of 60 to 85% by mass.
- the volatile fraction of the film-forming stock solution is 50% by mass or more, the viscosity of the film-forming stock solution does not become too high, and filtration and defoaming are smoothly performed during preparation of the film-forming stock solution, and there are few foreign matters and defects. Film production is facilitated.
- the volatile fraction of the film-forming stock solution is 95% by mass or less, the concentration of the film-forming stock solution does not become too low, and the production of an industrial PVA film becomes easy.
- the film forming stock solution preferably contains a surfactant.
- a surfactant By including the surfactant, the film-forming property is improved and the occurrence of uneven thickness of the PVA film is suppressed, and the PVA film is easily peeled off from the metal roll or belt used for film formation.
- the PVA film may contain a surfactant.
- the kind of said surfactant is not specifically limited, From a viewpoint of the peelability from a metal roll or a belt, an anionic surfactant or a nonionic surfactant is preferable.
- anionic surfactant for example, a carboxylic acid type such as potassium laurate; a sulfuric acid ester type such as polyoxyethylene lauryl ether sulfate and octyl sulfate; and a sulfonic acid type such as dodecylbenzene sulfonate are suitable.
- a carboxylic acid type such as potassium laurate
- a sulfuric acid ester type such as polyoxyethylene lauryl ether sulfate and octyl sulfate
- a sulfonic acid type such as dodecylbenzene sulfonate
- Nonionic surfactants include, for example, alkyl ether types such as polyoxyethylene oleyl ether; alkylphenyl ether types such as polyoxyethylene octylphenyl ether; alkyl ester types such as polyoxyethylene laurate; polyoxyethylene laurylamino Alkylamine type such as ether; alkylamide type such as polyoxyethylene lauric acid amide; polypropylene glycol ether type such as polyoxyethylene polyoxypropylene ether; alkanolamide type such as lauric acid diethanolamide and oleic acid diethanolamide; polyoxy An allyl phenyl ether type such as alkylene allyl phenyl ether is preferred.
- surfactants can be used alone or in combination of two or more.
- the content thereof is preferably in the range of 0.01 to 5 parts by mass with respect to 100 parts by mass of PVA contained in the film-forming stock solution, and 0.02 to 4 It is more preferably in the range of parts by mass, and particularly preferably in the range of 0.05 to 3 parts by mass.
- the content is 0.01 parts by mass or more, the film forming property and the peelability are further improved.
- the content is 5 parts by mass or less, it can be suppressed that the surfactant bleeds out to the surface of the PVA film to cause blocking and lower the handleability.
- Examples of the film forming method for forming a PVA film using the above-described film forming stock solution include a cast film forming method, an extrusion film forming method, a wet film forming method, and a gel film forming method. These film forming methods may be used alone or in combination of two or more. Among these film forming methods, the cast film forming method and the extrusion film forming method are preferable because a PVA film having uniform thickness and width and good physical properties can be obtained. The formed PVA film can be dried or heat-treated as necessary.
- a T-type slit die, a hopper plate, an I-die, a lip coater die or the like is used to rotate the above film forming stock solution on the most upstream side.
- the volatile component is uniformly discharged or cast on the peripheral surface of the first roll (or belt) and the volatile component is discharged from one surface of the film discharged or cast on the peripheral surface of the first roll (or belt).
- the method of winding with a winding device can be preferably employed industrially. Drying with a heated roll and drying with a hot air dryer may be performed in an appropriate combination.
- the surface of the PVA film is preferably matted for the purpose of improving the slip property of the surface.
- the mat treatment method include an on-line mat treatment method in which the surface of a mat on a roll or belt is transferred to a film during film formation, and a method in which an emboss treatment is performed after the formed film is once wound on a roll.
- the arithmetic average height (Ra) of the mat-treated surface is preferably 0.5 ⁇ m or more, and more preferably 1 ⁇ m or more.
- the upper limit of the arithmetic average height (Ra) is, for example, 10 ⁇ m from the viewpoint of pinhole resistance. When the arithmetic average height (Ra) is less than 0.5 ⁇ m, it is difficult to obtain sufficient slip properties.
- the maximum height (Rz) is preferably 1 ⁇ m or more, and more preferably 3 ⁇ m or more.
- the upper limit of the maximum height (Rz) is, for example, 20 ⁇ m from the viewpoint of pinhole resistance.
- the maximum height (Rz) is less than 0.5 ⁇ m, it is difficult to obtain sufficient slip properties.
- the arithmetic average height (Ra) and the maximum height (Rz) are defined by JIS B 0601: 2001.
- the PVA film of the present invention is preferably used as a drug packaging film because it dissolves quickly after being poured into water and has excellent diffusibility of the packaged drug.
- the medicine to be packaged include agricultural chemicals and detergents (including bleaching agents), and agricultural chemicals are preferable.
- the specific type of pesticide but it is preferably a jumbo agent because the effects of the present invention are more prominent.
- the form of the drug include powder, lump, gel, liquid and the like.
- the unit packaging which packages a chemical
- Model test for drug packaging The PVA film produced in the following examples or comparative examples was conditioned at 20 ° C. and 65% RH for 24 hours. Subsequently, 2.5 g of 3-4 mm ⁇ polyethylene pellets were hermetically packaged with a conditioned PVA film. Specifically, a bag is prepared by heat-sealing three sides so that the shape of the part containing the polyethylene pellets is a 30 mm ⁇ 30 mm square, and then the polyethylene pellets are put into this, and the remaining one is heat-sealed. And packaged. Next, 15 ° C.
- the water was introduced to a depth of 2 cm in an 18 cm ⁇ 25 cm bat, and the above-mentioned bag in which polyethylene pellets were packaged was floated on the water surface at the center of the bat.
- the time from when the bag floats on the surface of the water until the PVA film dissolves and the polyethylene pellets in the bag begin to diffuse into the surface of the water is defined as the bag breakage time. (Good) and the case where it exceeded 80 second was determined as solubility "x" (poor).
- solubility "x" solubility "x”
- the state of 180 seconds after the bag was floated on the surface of the water was photographed with a camera from above, and when the polyethylene pellet was diffused by 80% or more with respect to the area of the bat (450 cm 2 ), the diffusivity was “ ⁇ ”.
- the diffusivity was determined as “ ⁇ ” (slightly good), and when the diffusion was less than 60%, the diffusivity was “x” (bad) ).
- the bat is divided into 25 equal parts (one area is 3.6 cm ⁇ 5 cm), and if there is at least one polyethylene pellet in the equally divided area, the area is diffused. It was done by judging.
- Example 1 100 parts by mass of PVA (saponified product of vinyl acetate homopolymer) having a polymerization degree of 1,700 and a saponification degree of 88 mol%, 20 parts by mass of glycerin, 0.1 parts by mass of sodium polyoxyethylene lauryl ether sulfate, and Then, an aqueous solution containing 5 parts by mass of sodium dioctyl sulfosuccinate as a water surface spreading agent and having a PVA content of 10% by mass was prepared. This aqueous solution was dried and peeled off on a metal roll at 80 ° C. and then heat treated at 100 ° C. for 1 minute to produce a PVA film having a thickness of 40 ⁇ m. Using the obtained PVA film, a drug packaging model test was carried out by the method described above. The obtained results are shown in Table 1.
- Example 2 A PVA film having a thickness of 40 ⁇ m was produced in the same manner as in Example 1 except that the amount of sodium dioctylsulfosuccinate was changed to 1 part by mass. Using the obtained PVA film, a drug packaging model test was carried out by the method described above. The obtained results are shown in Table 1.
- Example 3 A PVA film having a thickness of 40 ⁇ m was produced in the same manner as in Example 1 except that the amount of sodium dioctylsulfosuccinate was changed to 10 parts by mass. Using the obtained PVA film, a drug packaging model test was carried out by the method described above. The obtained results are shown in Table 1.
- Example 4 A PVA film having a thickness of 40 ⁇ m was prepared in the same manner as in Example 1 except that 5 parts by mass of sodium di (2-ethylhexyl) sulfosuccinate was used as the water surface spreading agent in place of 5 parts by mass of sodium dioctyl sulfosuccinate. Manufactured. Using the obtained PVA film, a drug packaging model test was carried out by the method described above. The obtained results are shown in Table 1.
- Example 5 A PVA film having a thickness of 40 ⁇ m was produced in the same manner as in Example 3 except that the amount of glycerin used was changed to 35 parts by mass. Using the obtained PVA film, a drug packaging model test was carried out by the method described above. The obtained results are shown in Table 1.
- Example 6 Instead of 100 parts by mass of PVA (saponified vinyl acetate homopolymer) having a polymerization degree of 1,700 and a saponification degree of 88 mol%, a polymerization degree of 1,700, a saponification degree of 88 mol%, 2-acrylamido-2-methyl Example 1 except that 100 parts by mass of PVA (saponified copolymer of vinyl acetate and sodium 2-acrylamido-2-methylpropanesulfonate) having a sodium propanesulfonate unit content of 2 mol% was used. Similarly, a PVA film having a thickness of 40 ⁇ m was produced. Using the obtained PVA film, a drug packaging model test was carried out by the method described above. The obtained results are shown in Table 1.
- Example 7 A PVA film having a thickness of 40 ⁇ m was produced in the same manner as in Example 6 except that 10 parts by mass of glycerin and 10 parts by mass of diglycerin were used instead of 20 parts by mass of glycerin. Using the obtained PVA film, a drug packaging model test was carried out by the method described above. The obtained results are shown in Table 1.
- Example 8 A PVA film having a thickness of 40 ⁇ m was obtained in the same manner as in Example 6 except that 10 parts by mass of glycerin, 10 parts by mass of diglycerin and 5 parts by mass of polyethylene glycol having a number average molecular weight of 400 were used instead of 20 parts by mass of glycerin. Manufactured. Using the obtained PVA film, a drug packaging model test was carried out by the method described above. The obtained results are shown in Table 1.
- Example 1 A PVA film having a thickness of 40 ⁇ m was produced in the same manner as in Example 1 except that sodium dioctyl sulfosuccinate was not used. Using the obtained PVA film, a drug packaging model test was carried out by the method described above. The obtained results are shown in Table 1.
- Example 2 A PVA film having a thickness of 40 ⁇ m was produced in the same manner as in Example 1 except that 10 parts by mass of sodium allyl sulfonate was used instead of 5 parts by mass of sodium dioctyl sulfosuccinate. Using the obtained PVA film, a drug packaging model test was carried out by the method described above. The obtained results are shown in Table 1.
- Example 3 A PVA film having a thickness of 40 ⁇ m was produced in the same manner as in Example 1 except that the amount of glycerin used was changed to 5 parts by mass. Using the obtained PVA film, a drug packaging model test was carried out by the method described above. The obtained results are shown in Table 1.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Manufacturing & Machinery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mechanical Engineering (AREA)
- Materials Engineering (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Toxicology (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Manufacture Of Macromolecular Shaped Articles (AREA)
- Wrappers (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Description
[1]PVA、水面拡展剤および可塑剤を含み、可塑剤の含有量がPVA100質量部に対して10~40質量部であるPVAフィルム;
[2]水面拡展剤の含有量がPVA100質量部に対して0.1~15質量部である、[1]に記載のPVAフィルム;
[3]水面拡展剤がジアルキルスルホコハク酸塩である、[1]または[2]に記載のPVAフィルム;
[4]ジアルキルスルホコハク酸塩におけるアルキル基の少なくとも一方が炭素数6~12のアルキル基である、[3]に記載のPVAフィルム;
[5]ジアルキルスルホコハク酸塩におけるアルキル基の少なくとも一方が直鎖状のアルキル基である、[3]または[4]に記載のPVAフィルム;
[6]薬剤包装用フィルムである、[1]~[5]のいずれか1つに記載のPVAフィルム;
[7]薬剤が農薬または洗剤である、[6]に記載のPVAフィルム;
[8]薬剤を[6]または[7]に記載のPVAフィルムで包装してなる包装体;
に関する。 That is, the present invention
[1] A PVA film containing PVA, a water surface spreading agent and a plasticizer, wherein the plasticizer content is 10 to 40 parts by mass with respect to 100 parts by mass of PVA;
[2] The PVA film according to [1], wherein the content of the water surface spreading agent is 0.1 to 15 parts by mass with respect to 100 parts by mass of PVA;
[3] The PVA film according to [1] or [2], wherein the water surface spreading agent is a dialkyl sulfosuccinate.
[4] The PVA film according to [3], wherein at least one of the alkyl groups in the dialkylsulfosuccinate is an alkyl group having 6 to 12 carbon atoms;
[5] The PVA film according to [3] or [4], wherein at least one of the alkyl groups in the dialkylsulfosuccinate is a linear alkyl group;
[6] The PVA film according to any one of [1] to [5], which is a film for drug packaging;
[7] The PVA film according to [6], wherein the drug is an agrochemical or a detergent;
[8] A package formed by packaging the drug with the PVA film according to [6] or [7];
About.
上記のPVAとしては、酢酸ビニル、ギ酸ビニル、プロピオン酸ビニル、酪酸ビニル、ピバリン酸ビニル、バーサティック酸ビニル、ラウリン酸ビニル、ステアリン酸ビニル、安息香酸ビニル、酢酸イソプロペニル等のビニルエステルの1種または2種以上を重合して得られるポリビニルエステルをけん化することにより得られるものを使用することができる。上記のビニルエステルの中でも、PVAの製造の容易性、入手容易性、コスト等の点から、酢酸ビニルが好ましい。 [PVA]
The PVA is one of vinyl esters such as vinyl acetate, vinyl formate, vinyl propionate, vinyl butyrate, vinyl pivalate, vinyl versatate, vinyl laurate, vinyl stearate, vinyl benzoate, and isopropenyl acetate. Or what is obtained by saponifying the polyvinyl ester obtained by superposing | polymerizing 2 or more types can be used. Among the above vinyl esters, vinyl acetate is preferable from the viewpoints of ease of production of PVA, availability, cost and the like.
水面拡展剤の種類は特に制限されないが、本発明の効果がより顕著に奏されることなどからジアルキルスルホコハク酸塩が好ましい。当該ジアルキルスルホコハク酸塩は、スルホコハク酸塩における2つのカルボキシル基がそれぞれアルキルエステルに変換された構造に相当する構造を有する化合物であり、当該構造を有する限りどのような製造方法によって得られたものであってもよい。ジアルキルスルホコハク酸塩が有する2つのアルキルエステル部分における各アルキル基は互いに同じものであっても異なっていてもどちらでもよいが、製造が容易であることなどを考慮すると互いに同じものであることが好ましい。また、ジアルキルスルホコハク酸塩における上記アルキル基は、いずれか一方または両方が直鎖状のアルキル基であってもよいし、いずれか一方または両方が分岐鎖状のアルキル基であってもよい。当該アルキル基としては、例えば、メチル基、エチル基、プロピル基、イソプロピル基、ペンチル基、ヘキシル基、ヘプチル基、オクチル基、2-エチルヘキシル基、ノニル基、デカニル基、ウンデカニル基、ドデカニル基などが挙げられる。包装した薬剤の拡散性がより向上したPVAフィルムとなることなどから、ジアルキルスルホコハク酸塩におけるアルキル基の少なくとも一方(好ましくは両方)は、炭素数6~12のアルキル基であることが好ましく、炭素数7~10のアルキル基であることがより好ましい。また同様の理由により、ジアルキルスルホコハク酸塩におけるアルキル基の少なくとも一方(好ましくは両方)は、直鎖状のアルキル基であることが好ましい。 [Water surface spreading agent]
The type of the water surface spreading agent is not particularly limited, but dialkylsulfosuccinate is preferable because the effects of the present invention are more remarkably exhibited. The dialkylsulfosuccinate is a compound having a structure corresponding to a structure in which two carboxyl groups in the sulfosuccinate are each converted to an alkyl ester, and is obtained by any production method as long as it has the structure. There may be. The alkyl groups in the two alkyl ester moieties of the dialkyl sulfosuccinate may be the same or different from each other, but are preferably the same from the viewpoint of ease of production. . Further, either one or both of the alkyl groups in the dialkyl sulfosuccinate may be a linear alkyl group, or one or both may be a branched alkyl group. Examples of the alkyl group include methyl group, ethyl group, propyl group, isopropyl group, pentyl group, hexyl group, heptyl group, octyl group, 2-ethylhexyl group, nonyl group, decanyl group, undecanyl group, and dodecanyl group. Can be mentioned. In order to obtain a PVA film in which the diffusibility of the packaged drug is further improved, at least one (preferably both) of the alkyl groups in the dialkylsulfosuccinate is preferably an alkyl group having 6 to 12 carbon atoms. An alkyl group of 7 to 10 is more preferable. For the same reason, at least one (preferably both) of the alkyl groups in the dialkylsulfosuccinate is preferably a linear alkyl group.
上記の可塑剤としては、例えば多価アルコールが挙げられ、その具体例としては、エチレングリコール、グリセリン、プロピレングリコール、ジエチレングリコール、ジグリセリン、トリエチレングリコール、テトラエチレングリコール、トリメチロールプロパン、ポリエチレングリコールなどが挙げられる。PVAフィルムはこれらの可塑剤の1種または2種以上を含むことができる。これらの中でもグリセリン、ジグリセリンおよびポリエチレングリコールからなる群より選ばれる少なくとも1種が好ましい。ポリエチレングリコールの数平均分子量に特に制限はないが、PVAとの相容性や、またブリードアウトに起因したフィルムの水溶性低下を防止する観点から、100~1,000の範囲内であることが好ましい。 [Plasticizer]
Examples of the plasticizer include polyhydric alcohols, and specific examples thereof include ethylene glycol, glycerin, propylene glycol, diethylene glycol, diglycerin, triethylene glycol, tetraethylene glycol, trimethylolpropane, and polyethylene glycol. Can be mentioned. The PVA film can contain one or more of these plasticizers. Among these, at least one selected from the group consisting of glycerin, diglycerin and polyethylene glycol is preferable. The number average molecular weight of polyethylene glycol is not particularly limited, but may be in the range of 100 to 1,000 from the viewpoint of compatibility with PVA and prevention of reduction in water solubility of the film due to bleeding out. preferable.
機械的強度、取り扱う際の耐湿性、溶解する際の水の吸収による柔軟化の速度、水中での拡散に要する時間の調節などを目的として、PVAフィルムには、澱粉および/または上記PVA以外の他の水溶性高分子をさらに含有させてもよい。 [Other ingredients]
For the purpose of adjusting mechanical strength, moisture resistance during handling, speed of softening due to absorption of water when dissolving, time required for diffusion in water, etc., PVA films include starch and / or other than PVA. Another water-soluble polymer may be further contained.
以下の実施例または比較例で製造したPVAフィルムを20℃65%RHで24時間調湿した。続いて、3~4mmφのポリエチレンペレット2.5gを、調湿したPVAフィルムで密封包装した。具体的には、ポリエチレンペレットが入る部分の形状が30mm×30mmの正方形になるように、3方をヒートシールして袋を作製した上でこれにポリエチレンペレットを入れ、残りの一方をヒートシールすることにより包装した。次に、18cm×25cmのバットに、15℃の水を深さ2cmまで入れ、バットの中央の水面にポリエチレンペレットを包装した前記の袋を浮かべた。水面に袋を浮かべてからPVAフィルムが溶解して袋の中のポリエチレンペレットが水面に拡散しはじめるまでの時間を破袋時間とし、破袋時間が80秒以下の場合を溶解性が「○」(良好)と判定し、80秒を超える場合を溶解性が「×」(不良)と判定した。また、水面に袋を浮かべてから180秒後の様子を上部からカメラで撮影し、ポリエチレンペレットがバットの面積(450cm2)に対して80%以上拡散していた場合を拡散性が「○」(良好)と判定し、60%以上80%未満拡散していた場合を拡散性が「△」(やや良好)と判定し、60%未満拡散していた場合を拡散性が「×」(不良)と判定した。なお、拡散の判定において、バットの中を25等分(1エリアは3.6cm×5cm)し、その等分したエリアの中に1個でもポリエチレンペレットがあれば、そのエリアは拡散していると判段することにより行った。 Model test for drug packaging The PVA film produced in the following examples or comparative examples was conditioned at 20 ° C. and 65% RH for 24 hours. Subsequently, 2.5 g of 3-4 mmφ polyethylene pellets were hermetically packaged with a conditioned PVA film. Specifically, a bag is prepared by heat-sealing three sides so that the shape of the part containing the polyethylene pellets is a 30 mm × 30 mm square, and then the polyethylene pellets are put into this, and the remaining one is heat-sealed. And packaged. Next, 15 ° C. water was introduced to a depth of 2 cm in an 18 cm × 25 cm bat, and the above-mentioned bag in which polyethylene pellets were packaged was floated on the water surface at the center of the bat. The time from when the bag floats on the surface of the water until the PVA film dissolves and the polyethylene pellets in the bag begin to diffuse into the surface of the water is defined as the bag breakage time. (Good) and the case where it exceeded 80 second was determined as solubility "x" (poor). In addition, the state of 180 seconds after the bag was floated on the surface of the water was photographed with a camera from above, and when the polyethylene pellet was diffused by 80% or more with respect to the area of the bat (450 cm 2 ), the diffusivity was “◯”. (Good), when the diffusion was 60% or more and less than 80%, the diffusivity was determined as “△” (slightly good), and when the diffusion was less than 60%, the diffusivity was “x” (bad) ). In the determination of diffusion, the bat is divided into 25 equal parts (one area is 3.6 cm × 5 cm), and if there is at least one polyethylene pellet in the equally divided area, the area is diffused. It was done by judging.
重合度1,700、けん化度88モル%のPVA(酢酸ビニルの単独重合体のけん化物)を100質量部、グリセリンを20質量部、ポリオキシエチレンラウリルエーテル硫酸ナトリウムを0.1質量部、および、水面拡展剤としてジオクチルスルホコハク酸ナトリウムを5質量部を含み、PVAの含有率が10質量%である水溶液を作製した。この水溶液を80℃の金属ロール上で乾燥して剥離した後、100℃で1分間熱処理し、厚みが40μmのPVAフィルムを製造した。
得られたPVAフィルムを用いて、上記した方法により薬剤包装のモデル試験を実施した。得られた結果を表1に示した。 [Example 1]
100 parts by mass of PVA (saponified product of vinyl acetate homopolymer) having a polymerization degree of 1,700 and a saponification degree of 88 mol%, 20 parts by mass of glycerin, 0.1 parts by mass of sodium polyoxyethylene lauryl ether sulfate, and Then, an aqueous solution containing 5 parts by mass of sodium dioctyl sulfosuccinate as a water surface spreading agent and having a PVA content of 10% by mass was prepared. This aqueous solution was dried and peeled off on a metal roll at 80 ° C. and then heat treated at 100 ° C. for 1 minute to produce a PVA film having a thickness of 40 μm.
Using the obtained PVA film, a drug packaging model test was carried out by the method described above. The obtained results are shown in Table 1.
ジオクチルスルホコハク酸ナトリウムの使用量を1質量部に変更したこと以外は実施例1と同様にして、厚みが40μmのPVAフィルムを製造した。
得られたPVAフィルムを用いて、上記した方法により薬剤包装のモデル試験を実施した。得られた結果を表1に示した。 [Example 2]
A PVA film having a thickness of 40 μm was produced in the same manner as in Example 1 except that the amount of sodium dioctylsulfosuccinate was changed to 1 part by mass.
Using the obtained PVA film, a drug packaging model test was carried out by the method described above. The obtained results are shown in Table 1.
ジオクチルスルホコハク酸ナトリウムの使用量を10質量部に変更したこと以外は実施例1と同様にして、厚みが40μmのPVAフィルムを製造した。
得られたPVAフィルムを用いて、上記した方法により薬剤包装のモデル試験を実施した。得られた結果を表1に示した。 [Example 3]
A PVA film having a thickness of 40 μm was produced in the same manner as in Example 1 except that the amount of sodium dioctylsulfosuccinate was changed to 10 parts by mass.
Using the obtained PVA film, a drug packaging model test was carried out by the method described above. The obtained results are shown in Table 1.
水面拡展剤として、ジオクチルスルホコハク酸ナトリウム5質量部に代えて、ジ(2-エチルヘキシル)スルホコハク酸ナトリウム5質量部を用いたこと以外は実施例1と同様にして、厚みが40μmのPVAフィルムを製造した。
得られたPVAフィルムを用いて、上記した方法により薬剤包装のモデル試験を実施した。得られた結果を表1に示した。 [Example 4]
A PVA film having a thickness of 40 μm was prepared in the same manner as in Example 1 except that 5 parts by mass of sodium di (2-ethylhexyl) sulfosuccinate was used as the water surface spreading agent in place of 5 parts by mass of sodium dioctyl sulfosuccinate. Manufactured.
Using the obtained PVA film, a drug packaging model test was carried out by the method described above. The obtained results are shown in Table 1.
グリセリンの使用量を35質量部に変更したこと以外は実施例3と同様にして、厚みが40μmのPVAフィルムを製造した。
得られたPVAフィルムを用いて、上記した方法により薬剤包装のモデル試験を実施した。得られた結果を表1に示した。 [Example 5]
A PVA film having a thickness of 40 μm was produced in the same manner as in Example 3 except that the amount of glycerin used was changed to 35 parts by mass.
Using the obtained PVA film, a drug packaging model test was carried out by the method described above. The obtained results are shown in Table 1.
重合度1,700、けん化度88モル%のPVA(酢酸ビニルの単独重合体のけん化物)100質量部に代えて、重合度1,700、けん化度88モル%、2-アクリルアミド-2-メチルプロパンスルホン酸ナトリウム単位の含有率2モル%のPVA(酢酸ビニルと2-アクリルアミド-2-メチルプロパンスルホン酸ナトリウムとの共重合体のけん化物)100質量部を用いたこと以外は実施例1と同様にして、厚みが40μmのPVAフィルムを製造した。
得られたPVAフィルムを用いて、上記した方法により薬剤包装のモデル試験を実施した。得られた結果を表1に示した。 [Example 6]
Instead of 100 parts by mass of PVA (saponified vinyl acetate homopolymer) having a polymerization degree of 1,700 and a saponification degree of 88 mol%, a polymerization degree of 1,700, a saponification degree of 88 mol%, 2-acrylamido-2-methyl Example 1 except that 100 parts by mass of PVA (saponified copolymer of vinyl acetate and sodium 2-acrylamido-2-methylpropanesulfonate) having a sodium propanesulfonate unit content of 2 mol% was used. Similarly, a PVA film having a thickness of 40 μm was produced.
Using the obtained PVA film, a drug packaging model test was carried out by the method described above. The obtained results are shown in Table 1.
グリセリン20質量部に変えて、グリセリン10質量部およびジグリセリン10質量部を用いたこと以外は実施例6と同様にして、厚みが40μmのPVAフィルムを製造した。
得られたPVAフィルムを用いて、上記した方法により薬剤包装のモデル試験を実施した。得られた結果を表1に示した。 [Example 7]
A PVA film having a thickness of 40 μm was produced in the same manner as in Example 6 except that 10 parts by mass of glycerin and 10 parts by mass of diglycerin were used instead of 20 parts by mass of glycerin.
Using the obtained PVA film, a drug packaging model test was carried out by the method described above. The obtained results are shown in Table 1.
グリセリン20質量部に変えて、グリセリン10質量部、ジグリセリン10質量部および数平均分子量400のポリエチレングリコール5質量部を用いたこと以外は実施例6と同様にして、厚みが40μmのPVAフィルムを製造した。
得られたPVAフィルムを用いて、上記した方法により薬剤包装のモデル試験を実施した。得られた結果を表1に示した。 [Example 8]
A PVA film having a thickness of 40 μm was obtained in the same manner as in Example 6 except that 10 parts by mass of glycerin, 10 parts by mass of diglycerin and 5 parts by mass of polyethylene glycol having a number average molecular weight of 400 were used instead of 20 parts by mass of glycerin. Manufactured.
Using the obtained PVA film, a drug packaging model test was carried out by the method described above. The obtained results are shown in Table 1.
ジオクチルスルホコハク酸ナトリウムを用いなかったこと以外は実施例1と同様にして、厚みが40μmのPVAフィルムを製造した。
得られたPVAフィルムを用いて、上記した方法により薬剤包装のモデル試験を実施した。得られた結果を表1に示した。 [Comparative Example 1]
A PVA film having a thickness of 40 μm was produced in the same manner as in Example 1 except that sodium dioctyl sulfosuccinate was not used.
Using the obtained PVA film, a drug packaging model test was carried out by the method described above. The obtained results are shown in Table 1.
ジオクチルスルホコハク酸ナトリウム5質量部に代えて、アリルスルホン酸ナトリウム10質量部を用いたこと以外は実施例1と同様にして、厚みが40μmのPVAフィルムを製造した。
得られたPVAフィルムを用いて、上記した方法により薬剤包装のモデル試験を実施した。得られた結果を表1に示した。 [Comparative Example 2]
A PVA film having a thickness of 40 μm was produced in the same manner as in Example 1 except that 10 parts by mass of sodium allyl sulfonate was used instead of 5 parts by mass of sodium dioctyl sulfosuccinate.
Using the obtained PVA film, a drug packaging model test was carried out by the method described above. The obtained results are shown in Table 1.
グリセリンの使用量を5質量部に変更したこと以外は実施例1と同様にして、厚みが40μmのPVAフィルムを製造した。
得られたPVAフィルムを用いて、上記した方法により薬剤包装のモデル試験を実施した。得られた結果を表1に示した。 [Comparative Example 3]
A PVA film having a thickness of 40 μm was produced in the same manner as in Example 1 except that the amount of glycerin used was changed to 5 parts by mass.
Using the obtained PVA film, a drug packaging model test was carried out by the method described above. The obtained results are shown in Table 1.
ジオクチルスルホコハク酸ナトリウムを用いなかったこと以外は比較例3と同様にして、厚みが40μmのPVAフィルムを製造した。
得られたPVAフィルムを用いて、上記した方法により薬剤包装のモデル試験を実施した。得られた結果を表1に示した。 [Comparative Example 4]
A PVA film having a thickness of 40 μm was produced in the same manner as in Comparative Example 3 except that dioctyl sodium sulfosuccinate was not used.
Using the obtained PVA film, a drug packaging model test was carried out by the method described above. The obtained results are shown in Table 1.
Claims (8)
- ポリビニルアルコール、水面拡展剤および可塑剤を含み、可塑剤の含有量がポリビニルアルコール100質量部に対して10~40質量部であるポリビニルアルコールフィルム。 A polyvinyl alcohol film containing polyvinyl alcohol, a water surface spreading agent and a plasticizer, wherein the plasticizer content is 10 to 40 parts by mass with respect to 100 parts by mass of polyvinyl alcohol.
- 水面拡展剤の含有量がポリビニルアルコール100質量部に対して0.1~15質量部である、請求項1に記載のポリビニルアルコールフィルム。 The polyvinyl alcohol film according to claim 1, wherein the content of the water surface spreading agent is 0.1 to 15 parts by mass with respect to 100 parts by mass of polyvinyl alcohol.
- 水面拡展剤がジアルキルスルホコハク酸塩である、請求項1または2に記載のポリビニルアルコールフィルム。 The polyvinyl alcohol film according to claim 1 or 2, wherein the water surface spreading agent is a dialkylsulfosuccinate.
- ジアルキルスルホコハク酸塩におけるアルキル基の少なくとも一方が炭素数6~12のアルキル基である、請求項3に記載のポリビニルアルコールフィルム。 The polyvinyl alcohol film according to claim 3, wherein at least one of the alkyl groups in the dialkylsulfosuccinate is an alkyl group having 6 to 12 carbon atoms.
- ジアルキルスルホコハク酸塩におけるアルキル基の少なくとも一方が直鎖状のアルキル基である、請求項3または4に記載のポリビニルアルコールフィルム。 The polyvinyl alcohol film according to claim 3 or 4, wherein at least one of the alkyl groups in the dialkyl sulfosuccinate is a linear alkyl group.
- 薬剤包装用フィルムである、請求項1~5のいずれか1項に記載のポリビニルアルコールフィルム。 The polyvinyl alcohol film according to any one of claims 1 to 5, which is a drug packaging film.
- 薬剤が農薬または洗剤である、請求項6に記載のポリビニルアルコールフィルム。 The polyvinyl alcohol film according to claim 6, wherein the drug is an agrochemical or a detergent.
- 薬剤を請求項6または7に記載のポリビニルアルコールフィルムで包装してなる包装体。 A package formed by packaging the drug with the polyvinyl alcohol film according to claim 6 or 7.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015527715A JP6595913B2 (en) | 2014-02-06 | 2015-01-26 | Polyvinyl alcohol film |
KR1020167018455A KR102229234B1 (en) | 2014-02-06 | 2015-01-26 | Polyvinyl alcohol film |
CN201580007431.3A CN105940050B (en) | 2014-02-06 | 2015-01-26 | Polyvinyl alcohol film |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014021165 | 2014-02-06 | ||
JP2014-021165 | 2014-02-06 | ||
JP2014-044531 | 2014-03-07 | ||
JP2014044531 | 2014-03-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015118978A1 true WO2015118978A1 (en) | 2015-08-13 |
Family
ID=53777785
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2015/052003 WO2015118978A1 (en) | 2014-02-06 | 2015-01-26 | Polyvinyl alcohol film |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP6595913B2 (en) |
KR (1) | KR102229234B1 (en) |
CN (1) | CN105940050B (en) |
TW (1) | TWI639510B (en) |
WO (1) | WO2015118978A1 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017119434A (en) * | 2015-12-25 | 2017-07-06 | 日本合成化学工業株式会社 | Water-soluble film, medicine package, and manufacturing method of water-soluble film |
WO2019124310A1 (en) * | 2017-12-22 | 2019-06-27 | 株式会社クラレ | Polyvinyl alcohol film, film roll, and method for producing film roll |
WO2020031969A1 (en) * | 2018-08-07 | 2020-02-13 | 積水化学工業株式会社 | Water-soluble film for packaging, and package |
JP2020070372A (en) * | 2018-10-31 | 2020-05-07 | 三菱ケミカル株式会社 | Film coating composition, solid preparation and method for producing solid preparation |
WO2020138439A1 (en) * | 2018-12-28 | 2020-07-02 | 株式会社クラレ | Water-soluble film and package |
CN113227224A (en) * | 2018-12-28 | 2021-08-06 | 株式会社可乐丽 | Water-soluble film and package |
WO2022004345A1 (en) * | 2020-06-29 | 2022-01-06 | 株式会社クラレ | Water-soluble film and packaging |
WO2022004342A1 (en) * | 2020-06-29 | 2022-01-06 | 株式会社クラレ | Water-soluble film and packaging body |
CN114945522A (en) * | 2020-01-14 | 2022-08-26 | 株式会社爱赛璐 | Water-soluble film and medicine encapsulating capsule material with same function |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111954695B (en) * | 2018-04-10 | 2023-07-28 | 株式会社爱赛璐 | Water-soluble film |
CN112004881B (en) * | 2018-04-27 | 2023-03-10 | 株式会社可乐丽 | Polyvinyl alcohol film and method for producing polarizing film using same |
CN113226688B (en) * | 2018-12-28 | 2023-07-21 | 株式会社可乐丽 | Water-soluble film and package |
EP4219605A4 (en) | 2021-10-01 | 2023-11-01 | Kuraray Co., Ltd. | Water-soluble film, production method and package |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002012504A (en) * | 2000-04-28 | 2002-01-15 | Sankyo Co Ltd | Biodegradable floating foam on water surface having high oil absorbability, method for producing the same and composition containing the same |
JP2002020507A (en) * | 2000-07-13 | 2002-01-23 | Kuraray Co Ltd | Polyvinyl alcohol-based water-soluble film and method for producing the same |
JP2004155922A (en) * | 2002-11-07 | 2004-06-03 | Nippon Synthetic Chem Ind Co Ltd:The | Polyvinyl alcohol type film and preparation process therefor |
JP2010012778A (en) * | 2008-06-30 | 2010-01-21 | Lg Chem Ltd | Method of producing polyvinyl alcohol-based film, polyvinyl alcohol-based film formed by the same, and polarizing plate provided with the same |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5615202A (en) * | 1979-07-13 | 1981-02-14 | Kureha Chem Ind Co Ltd | Agricultural drug composition |
JP3118352B2 (en) | 1993-10-27 | 2000-12-18 | 株式会社クラレ | Water-soluble film for agricultural chemical packaging |
JPH0940834A (en) | 1995-07-28 | 1997-02-10 | Unitika Chem Kk | Polyvinyl alcohol film |
JPH10265302A (en) * | 1997-03-27 | 1998-10-06 | Nissan Chem Ind Ltd | Granular agrochemical for submerged application |
JP2003026504A (en) * | 2001-05-10 | 2003-01-29 | Sds Biotech:Kk | Urea-containing agrochemical solid formulation and method for producing the same |
CN102286183B (en) * | 2011-06-17 | 2013-09-11 | 包头市恒瑞新材料科技有限公司 | Plastic polyvinyl alcohol (PVA) resin and preparation method thereof |
-
2015
- 2015-01-26 JP JP2015527715A patent/JP6595913B2/en active Active
- 2015-01-26 KR KR1020167018455A patent/KR102229234B1/en active IP Right Grant
- 2015-01-26 CN CN201580007431.3A patent/CN105940050B/en active Active
- 2015-01-26 WO PCT/JP2015/052003 patent/WO2015118978A1/en active Application Filing
- 2015-02-04 TW TW104103653A patent/TWI639510B/en active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002012504A (en) * | 2000-04-28 | 2002-01-15 | Sankyo Co Ltd | Biodegradable floating foam on water surface having high oil absorbability, method for producing the same and composition containing the same |
JP2002020507A (en) * | 2000-07-13 | 2002-01-23 | Kuraray Co Ltd | Polyvinyl alcohol-based water-soluble film and method for producing the same |
JP2004155922A (en) * | 2002-11-07 | 2004-06-03 | Nippon Synthetic Chem Ind Co Ltd:The | Polyvinyl alcohol type film and preparation process therefor |
JP2010012778A (en) * | 2008-06-30 | 2010-01-21 | Lg Chem Ltd | Method of producing polyvinyl alcohol-based film, polyvinyl alcohol-based film formed by the same, and polarizing plate provided with the same |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017119434A (en) * | 2015-12-25 | 2017-07-06 | 日本合成化学工業株式会社 | Water-soluble film, medicine package, and manufacturing method of water-soluble film |
WO2019124310A1 (en) * | 2017-12-22 | 2019-06-27 | 株式会社クラレ | Polyvinyl alcohol film, film roll, and method for producing film roll |
JP7223709B2 (en) | 2017-12-22 | 2023-02-16 | 株式会社クラレ | POLYVINYL ALCOHOL FILM, FILM ROLL AND METHOD FOR PRODUCING FILM ROLL |
JPWO2019124310A1 (en) * | 2017-12-22 | 2020-12-24 | 株式会社クラレ | Polyvinyl alcohol film, film roll and film roll manufacturing method |
WO2020031969A1 (en) * | 2018-08-07 | 2020-02-13 | 積水化学工業株式会社 | Water-soluble film for packaging, and package |
JPWO2020031969A1 (en) * | 2018-08-07 | 2021-08-10 | 積水化学工業株式会社 | Water-soluble packaging film and packaging |
JP2020070372A (en) * | 2018-10-31 | 2020-05-07 | 三菱ケミカル株式会社 | Film coating composition, solid preparation and method for producing solid preparation |
JP7119913B2 (en) | 2018-10-31 | 2022-08-17 | 三菱ケミカル株式会社 | Film coating composition, solid formulation and method for producing solid formulation |
JPWO2020138439A1 (en) * | 2018-12-28 | 2021-11-11 | 株式会社クラレ | Water-soluble film and packaging |
CN113227224A (en) * | 2018-12-28 | 2021-08-06 | 株式会社可乐丽 | Water-soluble film and package |
WO2020138439A1 (en) * | 2018-12-28 | 2020-07-02 | 株式会社クラレ | Water-soluble film and package |
JP7344907B2 (en) | 2018-12-28 | 2023-09-14 | 株式会社クラレ | Water-soluble films and packaging |
CN113227224B (en) * | 2018-12-28 | 2023-09-19 | 株式会社可乐丽 | Water-soluble film and package |
CN114945522A (en) * | 2020-01-14 | 2022-08-26 | 株式会社爱赛璐 | Water-soluble film and medicine encapsulating capsule material with same function |
WO2022004345A1 (en) * | 2020-06-29 | 2022-01-06 | 株式会社クラレ | Water-soluble film and packaging |
WO2022004342A1 (en) * | 2020-06-29 | 2022-01-06 | 株式会社クラレ | Water-soluble film and packaging body |
Also Published As
Publication number | Publication date |
---|---|
TW201534473A (en) | 2015-09-16 |
TWI639510B (en) | 2018-11-01 |
JPWO2015118978A1 (en) | 2017-03-23 |
CN105940050A (en) | 2016-09-14 |
KR20160118226A (en) | 2016-10-11 |
KR102229234B1 (en) | 2021-03-17 |
JP6595913B2 (en) | 2019-10-23 |
CN105940050B (en) | 2018-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6595913B2 (en) | Polyvinyl alcohol film | |
JP7240420B2 (en) | Water-soluble film, method for producing the same, and package | |
WO2018230583A1 (en) | Water-soluble film, drug package, and production method for water-soluble film | |
JP7162077B2 (en) | Water-soluble film and packaging | |
JP7323018B2 (en) | Water-soluble film and drug package | |
WO2015020045A1 (en) | Film | |
JP2005089655A (en) | Polyvinyl alcohol resin and film | |
JPWO2020138441A1 (en) | Water-soluble film and packaging | |
JP7240421B2 (en) | Water-soluble film, method for producing the same, and package | |
WO2020138440A1 (en) | Water-soluble film and package | |
JP7344907B2 (en) | Water-soluble films and packaging | |
WO2020138442A1 (en) | Water-soluble film and packaging material | |
JP4601735B2 (en) | Polyvinyl alcohol film | |
JP7343732B2 (en) | Water-soluble film, manufacturing method and packaging | |
US11939441B2 (en) | Water-soluble film, manufacturing method, and package | |
WO2022004343A1 (en) | Water-soluble film and packaging | |
WO2022004342A1 (en) | Water-soluble film and packaging body | |
WO2022004345A1 (en) | Water-soluble film and packaging | |
JP2003311892A (en) | Polyvinyl alcohol resin film laminate and use therefor | |
CN115996878A (en) | Water-soluble film and package |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENP | Entry into the national phase |
Ref document number: 2015527715 Country of ref document: JP Kind code of ref document: A |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15746184 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 20167018455 Country of ref document: KR Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 15746184 Country of ref document: EP Kind code of ref document: A1 |